Skip to main content
Year archive

Ascentage Pharma Group International — 2026 filings

All 26 regulatory filings released by Ascentage Pharma Group International (6855) in 2026, sourced directly from the official regulator.

26 Filings
2026 Period
2026 filings (26)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY THE TRUSTEE FOR THE PURPOSE OF THE 2022 RSU SCHEME
Transaction in Own Shares
2026-05-28 English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY THE TRUSTEE FOR THE PURPOSE OF THE 2022 RSU SCHEME
Transaction in Own Shares
2026-05-27 English
DIS-APPLICATION OF RULES 18A.09 TO 18A.11 OF THE LISTING RULES AND REMOVAL OF STOCK MARKER
Regulatory Filings
2026-05-27 English
VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA RELEASES LATEST CLINICAL DATA FROM MULTIPLE TRIALS AT ASCO 2026
Regulatory Filings
2026-05-22 English
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2026-05-21 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 20, 2026
Declaration of Voting Results & Voting Rights Announcements
2026-05-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-07 English
SECOND FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 20, 2026
AGM Information
2026-04-30 English
SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2026-04-30 English
SUPPLEMENTAL CIRCULAR - PROPOSED GRANTS UNDER THE 2022 RSU SCHEME AND POST-IPO SHARE OPTION SCHEME TO DR. YANG AND DR. ZHAI; AND SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2026-04-30 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 20, 2026
Proxy Solicitation & Information Statement
2026-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2026-04-29 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND PROPOSED
Proxy Solicitation & Information Statement
2026-04-29 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2026-04-28 English
ANNUAL REPORT 2025
Annual Report FY 2025
2026-04-28 English
VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA TO PRESENT DATA FROM MULTIPLE TRIALS AT 2026 ASCO ANNUAL MEETING, INCLUDING THREE RAPID ORAL PRESENTATIONS
Regulatory Filings
2026-04-22 English
FURTHER GRANT OF AWARDS UNDER THE 2022 RSU SCHEME; AND FURTHER GRANT OF OPTIONS UNDER THE POST IPO SHARE OPTION SCHEME
Regulatory Filings
2026-04-20 English
VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA PRESENTS FOUR PROMISING PRECLINICAL STUDIES DEMONSTRATING THE POTENTIAL OF COMBINATION THERAPIES AT AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) 2026 ANNUA
Regulatory Filings
2026-04-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings
2026-04-09 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings
2026-04-01 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025; AND CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Earnings Release FY 2025
2026-03-25 English
VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA TO PRESENT DATA FROM FOUR PRECLINICAL STUDIES IN ITS INNOVATIVE PIPELINE AT AMERICAN ASSOCIATION OF CANCER RESEARCH (AACR) ANNUAL MEETING 2026
Regulatory Filings
2026-03-18 English
NOTICE OF BOARD MEETING
Regulatory Filings
2026-03-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings
2026-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change
2026-02-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change
2026-01-07 English